In a monumental leap for infant healthcare, the Food and Drug Administration (FDA) has granted approval to an R.S.V. (Respiratory Syncytial Virus) vaccine tailored exclusively for babies. This historic decision ushers in a new era of preventive care for our youngest generation. https://pressmaverick.com/fda-clears-path-for-r-s-v-vaccination-in-babies/